Ahmedabad, Dec 14 (IANS) In a move aimed at enhancing transparency and trust in the organ transplant system, the Gujarat government is developing a special registration software for patients awaiting kidney, liver, skin, heart valve and tissue transplants.
The state has a long waiting list of patients in need of organ transplants, many of whom have spent years in uncertainty due to the lack of information about their position on the cadaver (brain-dead donor) waiting list.
The proposed digital platform will allow registered patients to access real-time details of their status on the transplant waiting list, addressing a long-standing concern among recipients.
Pranjal R. Modi, Director of the Institute of Kidney Diseases and Research Centre (IKDRC) at Ahmedabad, said the initiative would bring much-needed clarity to the system and empower patients with accurate information.
At IKDRC, the state’s largest organ transplant centre, patients have welcomed the state government’s decision, noting that the software will enable them to check their waiting list number from home, reducing anxiety and repeated hospital visits.
“This will make the process far more patient-friendly,” said Sanjaybhai Patil, a kidney patient undergoing treatment at IKDRC.
The decision follows a meeting held on November 22 under the chairmanship of the Principal Secretary Raj Kumar, where measures to make Gujarat’s organ donation and transplant programme more transparent and reliable were discussed in detail.
Once operational, the new registration software is expected to bring greater transparency to procedures involving skin, heart valve, tissue, kidney, liver and bone transplants, while ensuring that patients receive timely and accurate information — marking a significant step forward in strengthening the state’s organ transplant framework.
Gujarat has steadily emerged as India’s pharmaceutical capital, driven by a robust manufacturing base, policy support and a strong ecosystem of research, talent and infrastructure.
The state accounts for a significant share of the country’s pharmaceutical production and exports, hosting major pharma hubs such as Ahmedabad, Vadodara, Ankleshwar, Vapi and Sanand, along with Asia’s largest common effluent treatment facilities that support sustainable manufacturing.
Home to leading Indian and global pharma companies, Gujarat benefits from seamless connectivity, port-led logistics, skilled manpower and proactive governance, making it a preferred destination for bulk drugs, formulations, vaccines and medical devices.
With continued investments, innovation-led growth and export orientation, Gujarat plays a pivotal role in ensuring affordable medicines for India and the world.
–IANS
janvi/khz
